Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
China · Delayed Price · Currency is CNY 4.830
+0.070 (1.47%)
Jun 18, 2026, 3:00 PM CST
SHA:600998 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 24,084 | 25,531 | 25,148 | 26,691 | 24,052 | 26,919 | |
Market Cap Growth | -6.58% | 1.52% | -5.78% | 10.97% | -10.65% | -19.02% |
Enterprise Value | 33,338 | 31,934 | 31,376 | 33,203 | 31,612 | 39,715 |
Last Close Price | 4.83 | 4.91 | 4.73 | 4.85 | 4.18 | 4.60 |
PE Ratio | 12.34 | 11.32 | 10.03 | 12.28 | 11.54 | 11.00 |
Forward PE | 10.88 | 11.38 | 12.69 | 10.60 | 9.52 | 10.44 |
PS Ratio | 0.15 | 0.16 | 0.17 | 0.18 | 0.17 | 0.22 |
PB Ratio | 0.64 | 0.69 | 0.75 | 0.91 | 0.84 | 0.99 |
P/TBV Ratio | 1.01 | 1.11 | 1.12 | 1.25 | 1.20 | 1.44 |
P/FCF Ratio | 9.90 | 12.52 | 11.94 | 7.22 | 8.77 | 12.99 |
P/OCF Ratio | 6.43 | 7.42 | 8.16 | 5.62 | 6.03 | 7.78 |
EV/Sales Ratio | 0.20 | 0.20 | 0.21 | 0.22 | 0.23 | 0.32 |
EV/EBITDA Ratio | 8.09 | 8.10 | 6.73 | 7.02 | 7.16 | 10.93 |
EV/EBIT Ratio | 9.83 | 9.57 | 8.00 | 8.19 | 8.34 | 12.86 |
EV/FCF Ratio | 13.71 | 15.66 | 14.89 | 8.98 | 11.53 | 19.16 |
Debt / Equity Ratio | 0.51 | 0.41 | 0.39 | 0.50 | 0.53 | 0.65 |
Debt / EBITDA Ratio | 4.65 | 3.68 | 2.76 | 3.05 | 3.35 | 4.67 |
Debt / FCF Ratio | 7.88 | 7.39 | 6.27 | 3.99 | 5.53 | 8.43 |
Net Debt / Equity Ratio | -0.02 | -0.11 | -0.15 | -0.08 | -0.08 | -0.04 |
Net Debt / EBITDA Ratio | -0.19 | -1.00 | -1.11 | -0.50 | -0.55 | -0.31 |
Net Debt / FCF Ratio | -0.30 | -1.94 | -2.45 | -0.64 | -0.88 | -0.54 |
Asset Turnover | 1.42 | 1.48 | 1.56 | 1.62 | 1.58 | 1.47 |
Inventory Turnover | 5.75 | 5.61 | 6.52 | 7.40 | 7.92 | 7.44 |
Quick Ratio | 0.80 | 0.73 | 0.81 | 0.83 | 0.85 | 0.90 |
Current Ratio | 1.25 | 1.25 | 1.27 | 1.26 | 1.27 | 1.29 |
Return on Equity (ROE) | 5.51% | 6.84% | 8.84% | 7.87% | 8.20% | 9.90% |
Return on Assets (ROA) | 1.84% | 1.91% | 2.51% | 2.74% | 2.66% | 2.31% |
Return on Invested Capital (ROIC) | 6.98% | 7.97% | 10.82% | 11.63% | 11.69% | 8.84% |
Return on Capital Employed (ROCE) | 8.20% | 8.30% | 10.90% | 12.40% | 11.60% | 10.10% |
Earnings Yield | 8.38% | 8.83% | 9.97% | 8.14% | 8.67% | 9.10% |
FCF Yield | 10.10% | 7.99% | 8.38% | 13.86% | 11.40% | 7.70% |
Dividend Yield | 4.20% | 4.07% | 4.23% | 4.00% | 4.45% | 2.42% |
Payout Ratio | 72.51% | 65.61% | 61.96% | 75.20% | 66.58% | 68.69% |
Buyback Yield / Dilution | -1.75% | -2.19% | 0.81% | 4.14% | -1.68% | 2.84% |
Total Shareholder Return | 2.42% | 1.88% | 5.04% | 8.14% | 2.76% | 5.26% |